AGENDA AT A GLANCE
8:00
Registration & Welcome Coffee
8:50
IMAPAC & Chairman's Welcome Address
Novel Formulation Strategies for Complex Biologics - mAbs, Bispecifics, & ADCs
9:00
Strategies to manage viscosity, aggregation, and injectability
- Balancing national manufacturing ambitions with economic realities
- Understanding the impact of government funding and policy initiatives
- Addressing fragmentation across European manufacturing ecosystems
- Defining strategies for sustainable and competitive growth
9:30
Overcoming Formulation Challenges for mRNA, saRNA, & Emerging Platforms
- Addressing instability and degradation challenges in RNA-based therapeutics
- Optimising lipid nanoparticle (LNP) and alternative delivery systems
- Improving storage, handling, and scalability of RNA formulations
- Translating novel RNA platforms from early development to clinical and commercial stages
10:30
Networking Break
Adjuvants & Immunostimulatory Technologies - Amplifying Vaccine Potency
11:10
Novel Platforms to Boost Immune Response while Enabling Dose Reduction
- Exploring innovative delivery systems and platforms to enhance immunogenicity
- Reducing dosage requirements while maintaining or improving efficacy
- Designing targeted and controlled immune activation strategies
- Balancing potency, safety, and manufacturability in next-gen platforms
11:40
Reserved for Solution Provider
12:10
Next-Generation Adjuvants: Enhancing Vaccine Potency and Immune Response
- Advancing adjuvant technologies to improve vaccine efficacy
- Understanding mechanisms of action and immune pathway activation
- Ensuring safety, tolerability, and regulatory compliance
- Scaling adjuvant-based formulations for global deployment
13:00
Lunch & Poster Presentation
Formulation Supply Chain – From Clinical to Commercial
14:00
From Clinical to Commercial: Building Scalable and Resilient Formulation Supply Chains
- Ensure consistent transition from clinical to commercial
- Secure materials and maintain reliable cold chain
14:30
Reserved for Solution Provider
15:00
Launch Forecasting, Inventory Strategy & Global Distribution Planning
- Developing accurate demand forecasting models to support successful product launches
- Aligning inventory strategy with production capacity, shelf-life, and market demand
- Managing global distribution challenges, including cold chain and regional variability
- Mitigating supply risks through scenario planning and end-to-end supply chain visibility
15:30
Networking Break
16:00
Interactive Roundtable Sessions:
- Formulation as a Commercial Differentiator: How early drug product decisions impact scalability and lifecycle value
- High-Concentration & Long-Acting Biologics: Balancing stability, delivery, and patient experience
- Scaling Complex Formulations to GMP: Avoiding tech transfer and manufacturing pitfalls
- AI & Predictive Tools in Formulation Development: Accelerating stability and optimisation strategies
- Patient-Centric Drug Product Design: Enabling self-administration and improved treatment accessibility
17:00
Cocktail Reception
18:00
END OF DAY 1
8:50
IMAPAC & Chairman's Welcome Address
Outsourcing for Early-Stage vs Late-Stage
9:00
Optimising LNP Formulations for mRNA Therapeutics: Stability, Delivery, and Performance
- Designing lipid ratios and formulations to enhance mRNA integrity, shelf-life, and storage stability
- Improving cellular uptake, targeting, and in vivo performance of LNP-based systems
9:30
Reserved for Solution Provider
10:00
Scaling RNA Drug Products: From LNP Design to Robust Manufacturing and Tech Transfer
- Translating LNP design from lab to GMP manufacturing with consistent performance
- Ensuring product quality and reproducibility through robust characterisation and process monitoring
10:30
Networking Break
From Formulation to Device Integration
11:10
Bridging Formulation and Device Development: Enabling Scalable and Patient-Centric Combination Products
- Align drug formulation with device requirements early to streamline development and avoid late-stage changes.
- Ensure products are easy to manufacture at scale while prioritizing usability, safety, and patient adherence.
11:40
Reserved for Solution Provider
12:10
Aligning Drug Product Design with Device Performance and Delivery Efficiency
- Ensure formulation properties align with device performance for accurate and consistent delivery.
- Optimize delivery to reduce variability and improve effectiveness and patient adherence.
13:00
Lunch & Poster Presentation
Smart Aseptic Fill–Finish
14:00
Smart Aseptic Fill–Finish: Leveraging Automation and Digitalisation for Sterile Manufacturing Excellence
- Reduce human intervention and enhance consistency using robotics and automated fill–finish systems.
- Enable monitoring, data-driven insights, and predictive maintenance to improve process reliability and efficiency.
- Leverage analytics and AI to detect deviations early, support predictive maintenance, and reduce batch failures
- Combine automation and digital platforms to create connected, efficient, and scalable aseptic production lines
14:30
Advancing Aseptic Fill–Finish Operations: Ensuring Sterility, Efficiency, and Scalable Production
- Strengthen contamination control through advanced barrier systems and strict environmental monitoring.
15:00
Innovations in Aseptic Fill–Finish: Enhancing Process Control, Contamination Prevention, and Throughput
- Use real-time monitoring and automation to ensure consistent quality and reduce variability.
- Enhanced Contamination Prevention Strategies
15:30
Networking Break
Closing Panel Discussion
16:00
CLOSING PANEL
Formulation in 2026: What Needs to Change Now
- Embracing Next-Generation Formulation Technologies
- Prioritize scalable manufacturing and formulations that improve patient experience and adherence
